178 related articles for article (PubMed ID: 38402381)
21. Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.
Krain RL; Kushner CJ; Tarazi M; Gaffney RG; Yeguez AC; Zamalin DE; Pearson DR; Feng R; Payne AS; Werth VP
Front Immunol; 2019; 10():2571. PubMed ID: 31781098
[TBL] [Abstract][Full Text] [Related]
22. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings.
Młynek A; Magerl M; Hanna M; Lhachimi S; Baiardini I; Canonica GW; Brzoza Z; Kasperska-Zajac A; Rogala B; Zalewska-Janowska A; Zuberbier T; Maurer M
Allergy; 2009 Jun; 64(6):927-36. PubMed ID: 19453340
[TBL] [Abstract][Full Text] [Related]
23. [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].
Leplège A; Ecosse E; Zeller J; Revuz J; Wolkenstein P
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):177-83. PubMed ID: 12671579
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting quality of life in patients with vitiligo: a nationwide study.
Bae JM; Lee SC; Kim TH; Yeom SD; Shin JH; Lee WJ; Lee MH; Lee AY; Kim KH; Kim MB; Park CJ; Lee SH; Kim DH; Lee HJ; Lee DY; Choi CW; Kim YC; Kang HY; Haw S; Lee YB; Yun SJ; Yun SK; Hong SP; Lee Y; Kim HJ; Choi GS
Br J Dermatol; 2018 Jan; 178(1):238-244. PubMed ID: 28391642
[TBL] [Abstract][Full Text] [Related]
25. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases.
Wolkenstein P; Zeller J; Revuz J; Ecosse E; Leplège A
Arch Dermatol; 2001 Nov; 137(11):1421-5. PubMed ID: 11708944
[TBL] [Abstract][Full Text] [Related]
26. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.
Essa N; Awad S; Nashaat M
Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis.
Kawakami T; Kimura S; Haga T; Doi R; Kyoya M; Nakagawa K; Soma Y
J Dermatol; 2012 Jun; 39(6):527-30. PubMed ID: 22035542
[TBL] [Abstract][Full Text] [Related]
28. Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.
Domon-Archambault V; Gagnon L; Benoît A; Perreault S
J Child Neurol; 2018 Mar; 33(3):225-232. PubMed ID: 29318935
[TBL] [Abstract][Full Text] [Related]
29. Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1.
Cipolletta S; Spina G; Spoto A
Child Care Health Dev; 2018 Mar; 44(2):260-268. PubMed ID: 28776749
[TBL] [Abstract][Full Text] [Related]
30. Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems.
Mautner VF; Granström S; Leark RA
J Atten Disord; 2015 Jan; 19(1):35-43. PubMed ID: 22786884
[TBL] [Abstract][Full Text] [Related]
31. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.
Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S
J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524
[TBL] [Abstract][Full Text] [Related]
32. A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1.
Hamoy-Jimenez G; Elahmar HA; Mendoza M; Kim RH; Bril V; Barnett C
Orphanet J Rare Dis; 2022 Feb; 17(1):40. PubMed ID: 35135568
[TBL] [Abstract][Full Text] [Related]
33. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study.
Tessari G; Dalle Vedove C; Loschiavo C; Tessitore N; Rugiu C; Lupo A; Girolomoni G
J Nephrol; 2009; 22(2):241-8. PubMed ID: 19384842
[TBL] [Abstract][Full Text] [Related]
34. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.
Oostenbrink R; Spong K; de Goede-Bolder A; Landgraf JM; Raat H; Moll HA
J Pediatr; 2007 Aug; 151(2):182-6, 186.e1-2. PubMed ID: 17643775
[TBL] [Abstract][Full Text] [Related]
35. Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.
Rosen AC; Case EC; Dusza SW; Balagula Y; Gordon J; West DP; Lacouture ME
Am J Clin Dermatol; 2013 Aug; 14(4):327-33. PubMed ID: 23625802
[TBL] [Abstract][Full Text] [Related]
36. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles.
Kim DY; Lee JW; Whang SH; Park YK; Hann SK; Shin YJ
J Dermatol; 2009 Jun; 36(6):317-22. PubMed ID: 19500179
[TBL] [Abstract][Full Text] [Related]
37. Evaluation and Factors of Quality of Life Among Patients With Neurofibromatosis Type 1-Associated Craniofacial Plexiform Neurofibromas.
Ren JY; Gu YH; Wei CJ; Huang X; Xu XW; Gu B; Zan T; Wang ZC; Li QF
J Craniofac Surg; 2020; 31(2):347-350. PubMed ID: 31977693
[TBL] [Abstract][Full Text] [Related]
38. Quality of life in patients with anogenital warts.
Paradisi A; Capizzi R; Ricci F; Di Pietro C; Abeni D; Tabolli S
Eur J Dermatol; 2013; 23(6):837-42. PubMed ID: 24192222
[TBL] [Abstract][Full Text] [Related]
39. Quality of Life in Adults with Neurofibromatosis 1 in Brazil.
Bicudo NP; de Menezes Neto BF; da Silva de Avó LR; Germano CM; Melo DG
J Genet Couns; 2016 Oct; 25(5):1063-74. PubMed ID: 26944915
[TBL] [Abstract][Full Text] [Related]
40. The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.
Buono FD; Sprong ME; Paul E; Martin S; Larkin K; Garakani A
Orphanet J Rare Dis; 2021 May; 16(1):234. PubMed ID: 34020694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
